Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT02595658
Eligibility Criteria:
Inclusion Criteria:
For inclusion in the study, volunteers will be -
* either male or female and aged 18-50 years old
* free from any diabetes complications apart from background diabetic retinopathy
* not taking any prescribed medication other than insulin
* treated with a stable insulin regimen composed of a combination of slow/long acting insulin glargine/determir and a fast acting insulin analogue (lispro or aspart, glulisine)
* have a HbA1c of \<9.5% (80 mmol/mol)
* using the carbohydrate counting method for administering meal time rapid-acting insulin.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02595658
Study Brief:
Protocol Section:
NCT02595658